Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: Possible role of the prolonged half-life of the immunogen

Vaccine

Volumn 27, Issue 6, 2009, Pages 857-863

  Zhang, Mei Yun ^a,b   Wang, Yanping ^a,b   Mankowski, Marie K ^c   Ptak, Roger G ^c   Dimitrov, Dimiter S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

Gp41; HIV AIDS; Vaccines

Indexed keywords

ANTIGEN; EPITOPE; GLYCOPROTEIN GP 41; GLYCOPROTEIN GP 41FC; HYBRID PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; NEUTRALIZING ANTIBODY; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; CONFORMATION; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS REACTION; DRUG HALF LIFE; EMBRYO; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; FEMALE; HALF-LIFE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV-1; HIV-2; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; NEUTRALIZATION TESTS; RABBITS; RECOMBINANT FUSION PROTEINS;

EID: 58249100316     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.11.083     Document Type: Article

References (16)

1. Karlsson Hedestam G.B., Fouchier R.A., Phogat S., Burton D.R., Sodroski J., and Wyatt R.T. The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat. Rev. Microbiol. 6 February 2 (2008) 143-155
2. Li Y., Migueles S.A., Welcher B., Svehla K., Phogat A., Louder M.K., et al. Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat. Med. 13 September 9 (2007) 1032-1034
3. Li Y., Svehla K., Mathy N.L., Voss G., Mascola J.R., and Wyatt R. Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants. J. Virol. 80 February 3 (2006) 1414-1426
4. Zhang P.F., Cham F., Dong M., Choudhary A., Bouma P., Zhang Z., et al. Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization. Proc. Natl. Acad. Sci. U S A 104 June 24 (2007) 10193-10198
5. Zhu X., Meng G., Dickinson B.L., Li X., Mizoguchi E., Miao L., et al. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J. Immunol. 166 March 5 (2001) 3266-3276
6. Zhang M.Y., Vu B.K., Choudhary A., Lu H., Humbert M., Ong H., et al. Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens. J. Virol. 82 July 14 (2008) 6869-6879
7. Choudhry V., Zhang M.Y., Sidorov I.A., Louis J.M., Harris I., Dimitrov A.S., et al. Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies. Virology 363 June 1 (2007) 79-90
8. Zhang M.Y., Choudhry V., Sidorov I.A., Tenev V., Vu B.K., Choudhary A., et al. Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning. J. Immunol. Methods 317 December 1-2 (2006) 21-30
9. Zhang M.Y., Shu Y., Phogat S., Xiao X., Cham F., Bouma P., et al. Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library. J. Immunol. Methods 283 December 1-2 (2003) 17-25
10. Ptak R.G., Gallay P.A., Jochmans D., Halestrap A.P., Ruegg U.T., Pallansch L.A., et al. Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent. Antimicrob. Agents Chemother. 52 April 4 (2008) 1302-1317
11. Buckheit Jr. R.W., and Swanstrom R. Characterization of an HIV-1 isolate displaying an apparent absence of virion-associated reverse transcriptase activity. AIDS Res. Hum. Retroviruses 7 March 3 (1991) 295-302
12. Ghetie V., and Ward E.S. Multiple roles for the major histocompatibility complex class I-related receptor FcRn. Annu. Rev. Immunol. 18 (2000) 739-766
13. Roopenian D.C., and Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat. Rev. Immunol. 7 September 9 (2007) 715-725
14. Ober R.J., Radu C.G., Ghetie V., and Ward E.S. Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. Int. Immunol. 13 December 12 (2001) 1551-1559
15. Kacskovics I., Kis Z., Mayer B., West Jr. A.P., Tiangco N.E., Tilahun M., et al. FcRn mediates elongated serum half-life of human IgG in cattle. Int. Immunol. 18 April 4 (2006) 525-536
16. Lin G., and Nara P.L. Designing immunogens to elicit broadly neutralizing antibodies to the HIV-1 envelope glycoprotein. Curr. HIV Res. 5 November 6 (2007) 514-541